Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Results from ongoing phase I/II trial of HE-3235 in CRPC disclosed

March 18, 2010

Third dose group treated in PCI Biotech's phase I/II trial of Amphinex in cancer

March 17, 2010

LLS and Forma to develop new therapies for diffuse large B-cell lymphoma

March 17, 2010

Advenchen claims new tyrosine kinase inhibitors for cancer therapy

March 17, 2010

Genentech discovers novel IAP inhibitors for treatment of cancer

March 17, 2010

Bio-Path receives FDA approval for clinical evaluation liposomal Grb-2 in cancer

March 16, 2010

Array BioPharma claims novel Pim kinase inhibitors

March 16, 2010

Novel MIF inhibitors identified by Yale University scientists for cancer therapy

March 16, 2010

Pfizer reports on phase III Sutent trials in advanced breast cancer

March 15, 2010

FDA approves 5-day dosing of Eisai's Dacogen for MDS

March 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...